Research project to develop temperature-adjustable retina laser launched

Article

A research project developing new technologies for laser treatments for the retina has been launched by the German Federal Ministry for Education and Research.

A research project developing new technologies for laser treatments for the retina has been launched by the German Federal Ministry for Education and Research. Collaboration partners on the project include Carl Zeiss Meditec, the Medical Laser Center, Lübeck, the Institute of Biomedical Optics of the University of Lübeck and the Eye Clinic of the University Hospital of Schleswig-Holstein, Germany.

The research project aims to develop a method for targeting precise doses of laser radiation to specific areas within the eye. The doses will be set automatically, to be as low as possible to reduce or eliminate side effects whilst being high enough to be optimally effective to conduct the treatment. The adjustable-temperature laser is intended to treat diseases such as diabetic retinopathy that affect a large portion of the retina.

The project was selected as the winner of the Ministry for Education and Research's "Innovation Competition for the Advancement of Medical Technology", and is anticipated to run for three years.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Related Content
© 2025 MJH Life Sciences

All rights reserved.